BridgeBio Pharma, Inc. (BBIO)
65.32
-0.85
(-1.28%)
USD |
NASDAQ |
Mar 06, 16:00
65.32
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Cash from Investing (TTM) : -22.34M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Insmed, Inc. | -64.58M |
| Mirum Pharmaceuticals, Inc. | -23.95M |
| Alphatec Holdings, Inc. | -53.41M |
| Supernus Pharmaceuticals, Inc. | 4.106M |
| Cogent Biosciences, Inc. | -399.53M |